Skip to main content
ResMedAsset sale

Frazier Healthcare Acquires MatrixCare, Appoints Lujan CEO

What happened

ResMed has sold its post-acute software company, MatrixCare, to private equity firm Frazier Healthcare Partners.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

geralt The private equity firm Frazier Healthcare Partners has acquired the post-acute software company MatrixCare from ResMed (NYSE: RMD). The transaction makes MatrixCare a standalone company, rather than a subsidiary. Financial terms were undisclosed. In the wake of the deal, the company appointed Frazier Executive in Residence Jonathan Lujan as CEO. Becoming a standalone corporation will enable MatrixCare to move more nimbly and focus more squarely on customer needs, according to Lujan. "We don't have to compete internally with a large parent company for attention and investment, against other businesses that were serving very different markets and different strategies and different priorities," Lujan told Hospice News. "This is going to allow us to make decisions faster, invest with greater focus, and really organize ourselves around our customers' priorities. Our commitment to customers does not change, just our ability to execute better and faster." MatrixCare is a provider of cloud-based electronic health record and revenue cycle management solutions purpose-built for post-acute care settings, including skilled nursing, senior living, home health, hospice and life plan communities. The company's priorities include product prioritization, improving interoperability and building out its automation and AI capabilities, Lujan said. "There are opportunities to reduce...

Keep reading with a free account

The rest of this article, and every signal for ResMed, is in your free account.

Extracted by Autobound

From the Signal API record
Event
Asset sale

What this signalsSelling part of the business often leads to a new focus and new budgets.

Companies

  • Frazier Healthcare PartnersAcquirerfrazierhealthcare.com

The full record

From the Signal API record

Details

Assets
post-acute software company

Topics and mentions

Asset tags

  • it
  • services

Extraction

Confidence
95%
Detected
Sep 11, 2026
signal_type
news
signal_subtype
sells_assets_to

Use this data

Get every asset sale signal for ResMed and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at ResMed this week?”

  2. Send it to your own tools

    The Signal API returns asset sale signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/ed3905ea-fb58-9992-a122-fb0301ee6d15 returns this record as JSON. POST /v1/companies/enrich returns every signal for resmed.com.

{
  "signal_id": "ed3905ea-fb58-9992-a122-fb0301ee6d15",
  "signal_type": "news",
  "signal_subtype": "sells_assets_to",
  "detected_at": "2026-09-11T13:35:52+00:00",
  "company": {
    "name": "ResMed",
    "domain": "resmed.com"
  },
  "data": {
    "url": "https://hospicenews.com/2026/09/11/frazier-healthcare-acquires-matrixcare-appoints-lujan-ceo/",
    "title": "Frazier Healthcare Acquires MatrixCare, Appoints Lujan CEO - Hospice News",
    "assets": "post-acute software company",
    "excerpt": "geralt The private equity firm Frazier Healthcare Partners has acquired the post-acute software company MatrixCare from ResMed (NYSE: RMD). The transaction makes MatrixCare a standalone company, rather than a subsidiary. Financial terms were undisclosed. In the wake of the deal, the company appointed Frazier Executive in Residence Jonathan Lujan as CEO. Becoming a standalone corporation will enable MatrixCare to move more nimbly and focus more squarely on customer needs, according to Lujan. “We don’t have to compete internally with a large parent company for attention and investment, against other businesses that were serving very different markets and different strategies and different priorities,” Lujan told Hospice News. “This is going to allow us to make decisions faster, invest with greater focus, and really organize ourselves around our customers’ priorities. Our commitment to customers does not change, just our ability to execute better and faster.” MatrixCare is a provider of cloud-based electronic health record and revenue cycle management solutions purpose-built for post-acute care settings, including skilled nursing, senior living, home health, hospice and life plan communities. The company’s priorities include product prioritization, improving interoperability and building out its automation and AI capabilities, Lujan said. “There are opportunities to reduce...",
    "summary": "ResMed has sold its post-acute software company, MatrixCare, to private equity firm Frazier Healthcare Partners.",
    "planning": false,
    "image_url": "https://hospicenews.com/wp-content/uploads/sites/6/2024/01/entrepreneur-1340649_1280.jpg",
    "confidence": 0.95,
    "assets_tags": [
      "it",
      "services"
    ],
    "published_at": "2026-09-11T13:35:52Z",
    "article_sentence": "The private equity firm Frazier Healthcare Partners has acquired the post-acute software company MatrixCare from ResMed (NYSE: RMD).",
    "related_company_name": "Frazier Healthcare Partners",
    "related_company_domain": "frazierhealthcare.com"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.